Cetuximab in metastatic mucinous adenocarcinoma of the colon

Abstract

The author brings a case of a patient with mucinous adenocarcinoma who takes place at the targeted therapy cetuximab for 35 months.

Keywords

• Mucinous adenocarcinoma
• right - sided colorectal cancer
• combination therapy
• cetuximab